Development and Metrological Characterization of a Multi-sensor Device for Indoor Environmental Quality (IEQ) monitoring

Indoor Environmental Quality (IEQ), which affects people's health, comfort, well-being and productivity, combines thermal, visual, acoustic and air quality conditions. This work deals with design, development and metrological characterization of a low-cost multi-sensor device that is able to detect the quality conditions of indoor environments for IEQ purposes. The device, hereafter referred as PROMET&O (PROactive Monitoring for indoor EnvironmenTal quality & cOmfort) embeds a set of low-cost sensors that measure air temperature and relative humidity, illuminance, sound pressure level, carbon monoxide, carbon dioxide, particulate matter, formaldehyde, and nitrogen dioxide. The basic architecture of the device is described and the design criteria that are related to the measurement requirements are highlighted. Particular attention has been paid towards the traceability assurance of the measurements provided by PROMET&O by means of specifically conceived calibration procedures, which have been tailored to the requirements of each measurement quantity. The calibration is based on the comparison to reference standards following commonly employed or ad-hoc developed technical procedures. The defined calibration procedures can be applied both for the single sensors and for the set of sensors integrated in the multi-sensor case. For the latter, the effects of the percentage of permeable case surface and the sensors allocation are also investigated. A preliminary uncertainty evaluation of the proposed multi-sensor device is reported for the carbon dioxide and the illuminance sensors taking the defined calibration procedures into account

DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene

Triplex-forming oligonucleotides (TFO) that bind DNA in a sequence-specific manner might be used as selective repressors of gene expression and gene-targeted therapeutics. However, many factors, including instability of triple helical complexes in cells, limit the efficacy of this approach. In the present study, we tested whether covalent linkage of a TFO to daunomycin, which is a potent DNA-intercalating agent and anticancer drug, could increase stability of the triple helix and activity of the oligonucleotide in cells. The 11mer daunomycin-conjugated GT (dauno-GT11) TFO targeted a sequence upstream of the P2 promoter, a site known to be critical for transcription of the c-myc gene. Band-shift assays showed that the dauno-GT11 formed triplex DNA with enhanced stability compared to the unmodified TFO. Band shift and footprinting experiments demonstrated that binding of dauno-GT11 was highly sequence-specific with exclusive binding to the 11 bp target site in the c-myc promoter. The daunomycin-conjugated TFO inhibited transcription in vitro and reduced c-myc promoter activity in prostate and breast cancer cells. The daunomycin-conjugated TFO was taken up by cells with a distinctive intracellular distribution compared to free daunomycin. However, cationic lipid-mediated delivery was required for enhanced cellular uptake, nuclear localization and biological activity of the TFO in cells. Dauno-GT11 reduced transcription of the endogenous c-myc gene in cells, but did not affect expression of non-target genes, such as ets-1 and ets-2, which contained very similar target sequences in their promoters. Daunomycin-conjugated control oligonucleotides unable to form triplex DNA with the target sequence did not have any effect in these assays, indicating that daunomycin was not directly responsible for the activity of daunomycin-conjugated TFO. Thus, attachment of daunomycin resulted in increased triplex stability and biological activity of the 11mer GT-rich TFO without compromising its specificity. These results encourage further testing of this approach to develop novel antigene therapeutics